World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
55622
World Ranking
11499
National Ranking
5894

Overview

Arlene A. Forastiere is affiliated with Johns Hopkins University in the United States. Their research primarily focuses on medicine, with substantial contributions to the subfields of otorhinolaryngology, pulmonary and respiratory medicine, surgery, oncology, and cancer research. Within these subjects, their work addresses several specialized topics including head and neck cancer studies, oral health in cancer treatment, head and neck surgical oncology, lung cancer treatments and mutations, salivary gland tumors diagnosis and treatment, cholangiocarcinoma, and gallbladder cancer studies, as well as lung cancer research studies.

The scientist has a notable record of publications in leading medical and oncology journals. Frequent publication venues include the European Journal of Cancer, Journal of Clinical Oncology, Research Square, Diagnostics, and Radiotherapy and Oncology.

Recent selected papers authored or co-authored by Forastiere include:

  • Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group, 2021, Radiotherapy and Oncology
  • Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis, 2021, The Lancet Oncology
  • A systematic review and recommendations on the use of plasma EBV DNA for nasopharyngeal carcinoma, 2021, European Journal of Cancer
  • Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099., 2023, Journal of Clinical Oncology
  • De-escalation studies in HPV-positive oropharyngeal cancer: How should we proceed?, 2021, Oral Oncology

The scientist collaborates regularly with a group of frequent co-authors, which include Alfio Ferlito, Barbara Burtness, Nabil F. Saba, Juan P. Rodrigo, and Athanassios Argiris. This suggests a collaborative network across clinical and research settings focused on oncology and head and neck cancer.

Best Publications

  • Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

    Arlene A. Forastiere;Helmuth Goepfert;Moshe Maor;Thomas F. Pajak

  • Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.

    Jay S. Cooper;Thomas F. Pajak;Arlene A. Forastiere;John Jacobs

  • Improved Survival of Patients With Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial

    Carole Fakhry;William H. Westra;Sigui Li;Anthony Cmelak

  • Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.

    M Al-Sarraf;M LeBlanc;P G Giri;K K Fu

  • HPV-associated head and neck cancer: a virus-related cancer epidemic

    Shanthi Marur;Gypsyamber D'Souza;William H Westra;Arlene A Forastiere

  • Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).

    Jacques Bernier;Jay S. Cooper;T. F. Pajak;M. Van Glabbeke

  • An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer

    David J. Adelstein;Yi Li;George L. Adams;Henry Wagner

  • Randomized Trial of Preoperative Chemoradiation Versus Surgery Alone in Patients With Locoregional Esophageal Carcinoma

    Susan G. Urba;Mark B. Orringer;Andrew Turrisi;Mark Iannettoni

  • Head and neck cancer.

    Arlene Forastiere;Wayne Koch;Andrew Trotti;David Sidransky

  • Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis

    Mitchell Machtay;Jennifer Moughan;Andrew Trotti;Adam S. Garden

  • Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer

    Arlene A. Forastiere;Qiang Zhang;Randal S Weber;Moshe H. Maor

  • Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study.

    Barbara Burtness;Meredith A. Goldwasser;William Flood;Bassam Mattar

  • Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment.

    Shanthi Marur;Arlene A. Forastiere

  • Head and neck cancer: changing epidemiology, diagnosis, and treatment.

    Shanthi Marur;Arlene A. Forastiere

  • TP53 mutations and survival in squamous-cell carcinoma of the head and neck.

    M. Luana Poeta;M. Luana Poeta;Judith Manola;Meredith A. Goldwasser;Arlene Forastiere

  • Association between Cigarette Smoking and Mutation of the p53 Gene in Squamous-Cell Carcinoma of the Head and Neck

    Joseph A. Brennan;Jay O. Boyle;Wayne M. Koch;Steven N. Goodman

  • Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study

    Ezra E.W. Cohen;Lee S. Rosen;Everett E. Vokes;Merrill S. Kies

  • Sequences of Taxol and Cisplatin: A Phase I and Pharmacologic Study

    E K Rowinsky;M R Gilbert;W P McGuire;D A Noe

  • American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer

    David G. Pfister;Scott A. Laurie;Gregory S. Weinstein;William M. Mendenhall

  • Activity of XL184 (cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer

    Razelle Kurzrock;Steven I. Sherman;Douglas W. Ball;Arlene A. Forastiere

Frequent Co-Authors

Randal S. Weber
Randal S. Weber The University of Texas MD Anderson Cancer Center
K. Kian Ang
K. Kian Ang The University of Texas MD Anderson Cancer Center
Wayne M. Koch
Wayne M. Koch Johns Hopkins University
Gregory T. Wolf
Gregory T. Wolf University of Michigan–Ann Arbor
Thomas F. Pajak
Thomas F. Pajak RTOG Foundation
William H. Westra
William H. Westra Icahn School of Medicine at Mount Sinai
David W. Eisele
David W. Eisele Johns Hopkins University
Adam S. Garden
Adam S. Garden The University of Texas MD Anderson Cancer Center
Maura L. Gillison
Maura L. Gillison The University of Texas MD Anderson Cancer Center
Helmuth Goepfert
Helmuth Goepfert The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn’t always mean becoming a doctor. There are several rewarding pathways and online degree options for those interested in healthcare. If you’re interested in managing patient data and technology, consider earning a health information technology online degree. These programs focus on data, security, and healthcare administration.

Another popular and accessible option is medical billing and coding, which can lead to a flexible work environment. Curious about program expenses? Find out how much does it cost to become a medical coder and budget for your education accordingly.

For those aiming to provide patient care, nurse practitioner programs offer an advanced route. By researching the most affordable nurse practitioner programs, you can find quality education that fits your financial needs. Or, if you’re just starting your nursing journey, explore the cheapest bsn programs online for a cost-effective path to your Bachelor of Science in Nursing.

These online options can help you launch or advance your healthcare career from anywhere, all while managing costs and work-life commitments.

Best Scientists Citing Arlene A. Forastiere

Trending Scientists

Recently Published Articles